HDAC inhibitors decrease mogamulizumab efficacy with downregulation of CCR4 in T-cell lymphoma

被引：0
|
作者：
Kitadate, Akihiro [1 ]
Ikeda, Sho [1 ]
Abe, Fumito [1 ]
Teshima, Kazuaki [1 ]
Takahashi, Naoto [1 ]
Matsue, Kosei [2 ]
Tagawa, Hiroyuki [1 ]
机构：
[1] Akita Univ, Sch Med, Dept Hematol Nephrol & Rheumatol, Akita 010, Japan
[2] Div Hematol, Akita 010, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
Malignant lymphoma; HDAC inhibitor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-2025
引用
收藏
页码：506 / 506
页数：1
相关论文
共 50 条
  • [41] Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma
    Ureshino, Hiroshi
    Kamachi, Kazuharu
    Kimura, Shinya
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (06): : 326 - 331
  • [42] Mechanisms of resistance to anti-CCR4 antibody, mogamulizumab, in cutaneous T cell lymphoma
    Beygi, Sara
    Fernandez-Pol, Sebastian
    Duran, George
    Wang, Erica B.
    Kim, Youn
    Khodadoust, Michael
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S8 - S8
  • [43] Mogamulizumab benefits seen in cutaneous T-cell lymphoma
    Tanday, Sanjay
    LANCET ONCOLOGY, 2015, 16 (05): : E200 - E200
  • [44] CD8+ T-cell-mediated Interface Dermatitis after CCR4+ T-cell Depletion by Mogamulizumab Treatment of Adult T-cell Leukaemia/lymphoma
    Ito, Ayako
    Sugita, Kazunari
    Adachi, Koji
    Hosoda, Yuzuru
    Motokura, Toru
    Yamamoto, Osamu
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (03) : 377 - 378
  • [45] An evaluation of mogamulizumab for the treatment of peripheral T-cell lymphoma
    Munakata, Wataru
    Tobinai, Kensei
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (07): : 735 - 742
  • [46] Population Pharmacokinetic Modeling of Mogamulizumab in Adults With Cutaneous T-Cell Lymphoma or Adult T-Cell Lymphoma
    Mukai, Mayumi
    Maeda, Hiroshi
    Narushima, Kazuya
    Mould, Diane R.
    Greene, Douglas
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (01): : 58 - 66
  • [47] Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
    Atae Utsunomiya
    Retrovirology, 11 (Suppl 1)
  • [48] MOGAMULIZUMAB FOR THE TREATMENT OF ADULT T-CELL LEUKEMIA/LYMPHOMA
    de Lartigue, J.
    DRUGS OF TODAY, 2012, 48 (10) : 655 - 660
  • [49] Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma
    Nakagawa, Masao
    Schmitz, Roland
    Xiao, Wenming
    Goldman, Carolyn K.
    Xu, Weihong
    Yang, Yandan
    Yu, Xin
    Waldmann, Thomas A.
    Staudt, Louis M.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (13): : 2497 - 2505
  • [50] HDAC INHIBITORS IN T-CELL LYMPHOMAS
    Coiffier, B.
    ANNALS OF ONCOLOGY, 2011, 22 : 256 - 256
12345